Looks like it’s almost bounced back to pre CRL number 2 price levels…more shares are on issue but the probability of success is higher, likely evening out the dilution at 30 cents.
approval for the indication a huge point of validation for the company and game changing from a revenue and potentially profit making perspective.
where is that guy who warns the mums and dads 5 am every morning out of the goodness of his heart? MIA?
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-510
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |